Luforbec is a inhaled combination therapy containing beclometasone (100mcg) and formoterol (6mcg) in a pressurised metered dose inhaler (pMDI).
Luforbec is indicated for the treatment of adult asthma and for the symptomatic treatment of COPD (FEV1 <50% predicted normal)2
Release savings with the first branded generic alternative to Fostair® 100/6 pMDI1
Save 30% with Luforbec 100/6 pMDI vs Fostair 100/6 pMDI list price1
brand to release savings
Fostair 100/6 pMDI and Luforbec 100/6 pMDI are both Category C medicines, therefore Luforbec must be prescribed by brand to release savings for the NHS1
If you would like to know more about Luforbec and the savings opportunities available, please get in touch by email to:
UKRespiratory@lupin.com or call on: 01565 751378